Data / Form D filings / Rezolute, Inc.
Rezolute, Inc.: Form D filings
Rezolute, Inc., a biotechnology company in Redwood City, CA, filed 16 Form D notices with the SEC between 2011 and 2020. The latest, on October 22, 2020, reports $41 million sold of a $57 million offering to 12 investors.
Find out what Rezolute, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 Redwood Shores Pkwy, Suite 315, Redwood City, CA, 94065
- Phone
- (650) 206-4507
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1509261
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22, 2020 | New notice | $56,990,020 | $41,000,000 | $15,990,020 | 12 | Oct 9, 2020 | sec.gov |
| Apr 24, 2018 | Amendment | $6,000,000 | $4,800,000 | $1,200,000 | 34 | Jan 30, 2018 | sec.gov |
| Feb 15, 2018 | New notice | $750,000 | $500,000 | $250,000 | 1 | Jan 30, 2018 | sec.gov |
| Feb 7, 2018 | Amendment | $25,431,894 | $3,360,000 | $22,071,894 | 190 | Jan 31, 2017 | sec.gov |
| Jan 11, 2018 | New notice | $10,137,868 | $137,868 | $10,000,000 | 1 | Dec 22, 2017 | sec.gov |
| May 31, 2017 | New notice | $15,000,000 | $6,726,190 | $8,273,810 | 5 | Mar 6, 2017 | sec.gov |
| Feb 14, 2017 | New notice | $25,431,894 | $3,360,000 | $22,071,894 | 190 | Jan 31, 2017 | sec.gov |
| Jul 13, 2016 | New notice | $53,300,000 | $5,362,521 | $47,937,479 | 60 | Jun 24, 2016 | sec.gov |
| Mar 22, 2016 | Amendment | $16,709,995 | $4,347,615 | $12,362,380 | 11 | Dec 10, 2015 | sec.gov |
| Dec 21, 2015 | New notice | $15,150,008 | $2,000,115 | $13,149,893 | 6 | Dec 10, 2015 | sec.gov |
| Apr 14, 2015 | New notice | $4,702,703 | $1,984,012 | $2,718,691 | 14 | Mar 31, 2015 | sec.gov |
| Jan 26, 2015 | New notice | $35,270,270 | $6,925,580 | $28,344,690 | 73 | Nov 28, 2014 | sec.gov |
| Apr 28, 2014 | Amendment | $26,250,000 | $8,931,433 | $17,318,567 | 113 | Mar 31, 2014 | sec.gov |
| Apr 14, 2014 | New notice | $26,250,000 | $7,296,453 | $18,953,547 | 82 | Mar 31, 2014 | sec.gov |
| Jan 14, 2014 | New notice | $3,500,000 | $1,420,000 | $2,080,000 | 7 | Dec 23, 2013 | sec.gov |
| May 17, 2011 | New notice | $6,000 | $6,000 | $0 | 6 | Oct 1, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Keith Charles Vendola | Executive Officer | |
| Young-Jin Charles Kim | Director | |
| Jung-Hee Charles Lim | Director | |
| Philippe Charles Fauchet | Director | |
| Sankaram Charles Mantripragada | Executive Officer | |
| Nevan Charles Elam | Executive Officer, Director | |
| Gil Charles Labrucherie | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Oct 19, 2020 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rezolute, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.